Alexander Khromykh

Professor

University of Queensland

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Alexander Khromykh is a faculty member at the University of Queensland, Australia. His research focuses on virology, particularly the structure and function of flavivirus proteins, development of vaccines and therapeutics for SARS-CoV-2, and the discovery of novel viruses in various hosts. He has published extensively on topics such as antiviral mechanisms, immune responses to viruses, and the generation of monoclonal antibodies targeting emerging viral variants.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Mette Marie Rosenkilde

Københavns Universitet

DENMARK

Alexander Khromykh

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Xinyang flavivirus, from Haemaphysalis flava ticks in Henan Province, China, defines a basal, likely tick-only Orthoflavivirus clade

The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics

Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light

A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK

Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs

GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection

Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells

Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems

Reporter Flaviviruses as Tools to Demonstrate Homologous and Heterologous Superinfection Exclusion

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate

Collaborators (22)

Mette Marie Rosenkilde

Naphak Modhiran

Vito Ferro

Helen Faddy

Matthew J. Sweet

Sébastian Lequime

Frédéric A Meunier

Tobias Kollmann

David Martino

Lachlan De Hayr

Robert Gifford

Larisa Labzin

Louis Lambrechts

Katharina Ronacher

Michael T. Wolfinger

Michael Landsberg

Ariel Isaacs

Waleed M. Hussein

Cheng Xiang Foo

Mariusz Skwarczynski

Jody Hobson-Peters

Margus Varjak

Make your next move.